Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLESONIDE Cause Pain in extremity? 255 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Pain in extremity have been filed in association with CICLESONIDE (Alvesco). This represents 4.4% of all adverse event reports for CICLESONIDE.

255
Reports of Pain in extremity with CICLESONIDE
4.4%
of all CICLESONIDE reports
47
Deaths
230
Hospitalizations

How Dangerous Is Pain in extremity From CICLESONIDE?

Of the 255 reports, 47 (18.4%) resulted in death, 230 (90.2%) required hospitalization, and 119 (46.7%) were considered life-threatening.

Is Pain in extremity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLESONIDE. However, 255 reports have been filed with the FAERS database.

What Other Side Effects Does CICLESONIDE Cause?

Asthma (4,026) Dyspnoea (2,953) Wheezing (2,785) Therapeutic product effect incomplete (2,337) Loss of personal independence in daily activities (1,575) Obstructive airways disorder (1,403) Cough (1,395) Sleep disorder due to a general medical condition (1,333) Full blood count abnormal (916) Productive cough (847)

What Other Drugs Cause Pain in extremity?

ADALIMUMAB (18,319) ETANERCEPT (14,837) METHOTREXATE (9,932) TOFACITINIB (8,675) SECUKINUMAB (6,700) TERIPARATIDE (6,012) TOCILIZUMAB (5,670) ABATACEPT (5,608) RITUXIMAB (5,080) PREGABALIN (5,023)

Which CICLESONIDE Alternatives Have Lower Pain in extremity Risk?

CICLESONIDE vs CICLOPIROX CICLESONIDE vs CICLOPIROX OLAMINE CICLESONIDE vs CICLOSPORIN CICLESONIDE vs CIDOFOVIR CICLESONIDE vs CILASTATIN

Related Pages

CICLESONIDE Full Profile All Pain in extremity Reports All Drugs Causing Pain in extremity CICLESONIDE Demographics